Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vancomycin in Primary Sclerosing Cholangitis
NCT02605213Phase 4Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2015
- Primary completion
- Feb 2016
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Primary Sclerosing Cholangitis (PSC), sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
vancomycin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT02605213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605213.